Forbion Spins Out of ABN Amro Capital

Forbion Capital Partners has launched as a spinout of the life sciences VC team of ABN Amro Capital. Its initial fund is Euro 200 million, with ABN Amro holding a 25% stake and Coller Capital underwriting the remainder. www.forbion.com